Drug companies continue controversial prices hikes
A recent article in the Wall Street Journal as well as analyst commentary noted that Pfizer Inc., Amgen Inc., Allergan PLC and others have hiked up dozens of U.S. drug prices since December, with many of the increases at nearly 9 percent and 10 percent. Read More »